drugset / Trial / NCT00754832
American Ginseng Treatment for Multiple Sclerosis Related Fatigue
Phase 2
Completed
56 enrolled
Oregon Health and Science University
National Multiple Sclerosis Society · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This research project will determine the safety and tolerability of ginseng in subjects with MS and will gather preliminary data on the efficacy of ginseng vs placebo for the treatment of MS fatigue.
Timeline
- Start
- 2005-09
- Primary completion
- 2008-09
- Completion
- 2011-03
Publications
- Results Kim E, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Mult Scler. 2011 Dec;17(12):1523-6. doi: 10.1177/1352458511412062. Epub 2011 Jul 29.
- Kim E, Lovera J, Schaben L, Melara J, Bourdette D, Whitham R. Novel method for measurement of fatigue in multiple sclerosis: Real-Time Digital Fatigue Score. J Rehabil Res Dev. 2010;47(5):477-84. doi: 10.1682/jrrd.2009.09.0151.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | American ginseng | Unknown | 400 mg | Oral |